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Synthesis of glycosylphosphatidylinositol
(GPI)-anchor glycolipids bearing unsaturated lipids†
B.-Y. Lee,a P. H. Seebergerab and D. Varon Silva*ab
2-Naphthyl-methyl ethers as permanent protecting groups are
readily removed under acidic conditions and are key to the synthesis
of complex glycosylphosphatidylinositol anchors containing unsaturated
lipids. The total synthesis of the GPI pseudo-disaccharide core found
on the surface of the Trypanosoma cruzi parasite serves to illustrate
the power of the strategy.
GPIs are complex glycolipids that are ubiquitous in eukaryotic
cells and have a common pseudo-pentasaccharide core structure
6-O-NEtP-Mana1-2-Mana1-6-Mana1-4-GlcNa1-6-Ino-1-P (Fig. 1).1
This conserved core is generally modified by additional phos-
phorylations, glycosylations, or acylations at the 2-O position of
the myo-inositol in a cell-type dependent manner.2 GPIs are
heterogeneous in the glycan as well as the lipid part. Inositol can
bear sn-1-alkyl-2-acylglycerol, sn-1,2-diacylglycerol, or ceramide
adorned with lipid chains of different lengths and degrees of
saturation.3
Chagas disease, caused by the parasite Trypanosoma cruzi
(T. cruzi), is a major public health problem in Latin America,
infects around 7–8 million persons worldwide, and causes
more than 10 000 deaths each year.4 There is no vaccine for
this disease and the two drugs available for treatment are used
sparingly due to their cost, side effects, and low antiparasitic
activity in patients with chronic infections.5
The cell surface of T. cruzi contains a high concentration of
glycosylphosphatidylinositol (GPI) molecules, which exhibit
proinflammatory activities comparable to bacterial lipopolysac-
charides and are predominately attached to highly glycosylated
mucins and phosphoglycans.6,7 Structural hallmarks of these
GPIs are a glycan branch of galactoses, a T. cruzi specific
2-aminoethylphosphonate (2-AEP) unit at the 6-O position of
the glucosamine residue and the presence of unsaturated fatty
acids in the phospholipid,8,9 which have been associated with
the biological activity of these molecules.6,10
Isolation of homogeneous GPIs is extremely difficult due to
the heterogeneity and amphiphilic character of both the glycan
and lipid. Biological evaluation of T. cruzi GPIs and potential
applications for the diagnosis and prevention of Chagas disease
require synthetic GPIs bearing unsaturated lipids. Most synthetic
strategies for GPI glycolipids use benzyl ethers as permanent
carbohydrate protecting groups. However, the reductive conditions
required for benzyl ether removal are not compatible with the
double bonds present in the lipid moiety.11 While this issue can be
avoided through the use of benzoyl esters or PMB ethers,12,13 their
use in this application has been limited due to the saponification
of the fatty acid esters during base-mediated benzoyl ester
removal and the low stability of PMB ethers under the mild
acidic conditions commonly used for glycosylations.13–15
While the 2-naphthylmethyl ether (Nap) group has primarily
been used as a temporary mask for hydroxyl groups in carbohydrate
chemistry,16,17 its stability during glycosylation reactions and its
orthogonality to silyl ethers, acyl esters, and even PMB ethers make
it the ideal group for permanent protection during GPI synthesis.
Fig. 1 Glycosylphosphatidylinositol anchor of the parasite Trypanosoma
cruzi.
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Herein, we report an efficient strategy for the synthesis of
GPIs bearing unsaturated lipids. The key of our strategy is the
use of stable 2-naphthylmethyl ethers for permanent hydroxyl
group protection, which are readily removed using acidic conditions.
The strategy is illustrated for the synthesis of a portion of the
GPI anchor from T. cruzi.
We considered an assembly sequence based on our recently
reported strategy for accessing GPIs with saturated lipids, in
which the glycan is assembled first and the phosphorylations
are installed at a late-stage of the synthesis.17,18 In this strategy,
Nap ethers replaced the benzyl ethers as permanent protecting
groups and the Allyl and PMB ethers were included as temporary
protecting groups for positions requiring phosphorylation,
while an azide served as a masked amine.
To obtain the bis-phosphorylated GPI pseudo-disaccharide
2, a number of building blocks were envisioned branching from
the core glycan fragment 3 containing Nap ethers as permanent
protecting groups. For the subsequent phosphorylations, building
blocks 4 and 5 were necessitated (Fig. 2). To assemble the glycan
moiety, building blocks 6 and 7 were designed to generate the
desired a-glucosylated myo-inositol. Through a series of protecting
group manipulations, the pseudo-disaccharide glycan GlcN-Ino
3 was obtained with both a PMB and an allyl-protecting group.
Selective step-wise removal of the PMB and allyl ethers, followed
by phosphorylations and global deprotection, will complete the
synthesis.
Synthesis of the protected optically pure D-myo-inositol
building block 7 started from methyl-glucoside.19,20 The primary
alcohol was protected with a trityl group, followed by the overnight
per-naphthyl-methylation using 2-(naphthyl)-methyl bromide and
NaH (Scheme 1). After removal of the trityl ether, alcohol oxidation
with SO3-pyridine complex to the aldehyde, and subsequent
acetylation produced enol-ester 10. A mercury II-mediated Ferrier
type-2 rearrangement afforded intermediate 11 in good yield
(68%). Stereoselective reduction of ketone 11 with NaBH(OAc)3
followed by deacetylation under Zemplen conditions delivered triol
12. Regioselective allylation of 12 using bis(tributyltin) oxide and
the selective protection at O-2 as a napthyl-methyl ether gave
building block 7 in 19% overall yield. The Nap group did not
affect the process when compared to benzyl ethers and delivered
the protected myo-inositol with improved yield.20
For the synthesis of GlcN-Ino pseudo-disaccharide 3, the
required glucosamine donor 6 was obtained from glucosamine
azide 13 by transformation of the anomeric acetyl group into a
trichloroacetimidate using a two-step protocol. Three different
conditions were tested to obtain the desired a-glycosidic linkage.21
Product 14 was obtained in the best a/b ratio (11 : 1) at room
temperature, using Et2O/CH2Cl2 as solvent and TMSOTf as an
activator (Scheme 2).
After separation of the a/b isomers of 14 by silica gel
chromatography, the acetyl groups were removed using Zemplen
conditions and the 4-O and 6-O hydroxyls were protected as a
p-methoxybenzylidene acetal by reacting the generated triol
with anisaldehyde dimethylacetal under acidic conditions.
Nap protection of the free 3-O position of disaccharide 15,
followed by selective opening of the 4,6-acetal group using
NaCNBH3 under acidic conditions, and protection of the 4-O
position delivered the fully protected 3 in good yield (Scheme 2).
With the glycan part in hand, the synthesis of the phos-
phorylated building blocks 4 and 5 was advanced. Etherification
of alcohol 17 using 1-bromooctadecane and NaH, followed by
the hydrolysis of the isopropylidene acetal and subsequent
protection of the primary alcohol using a TBS group furnished
19 (Scheme 3a).
Fig. 2 Retrosynthetic analysis of the T. cruzi GPI pseudo-disaccharide
containing an unsaturated lipid chain.
Scheme 1 Synthesis of protectedmyo-inositol 7. Reaction conditions: (a)
NapBr, NaH, DMF, rt, overnight, 85%; (b) p-TsOH, MeOH, rt, 16 h, 90%; (c) i.
SO3-Py, DIPEA, DMSO, CH2Cl2, 0 1C, 1 h, ii. Ac2O, K2CO3, MeCN, reflux,
4 h, 80% (2 steps); (d) i. Hg(OTf)2, acetone/H2O, rt, 1 h, ii. NaOAc, NaCl,
0 1C to rt, 12 h; (e) NaBH(OAc)3, MeCN, AcOH, rt, 12 h, 68% (2 steps);
(f) NaOMe, MeOH, rt, 30 min; (g) i. (Bu3Sn)2O, toluene, reflux, 5 h, ii. AllBr,
TBAI, toluene 65 1C, 17 h, 68% (20% recovered starting material); (h) NapBr,
NaH, DMF, 20 1C to 0 1C, 2 h, 67%.
Scheme 2 Synthesis of Glc-Ino pseudo-disaccharide 3. Reaction conditions:
(a) i. NH3(g), CH3CN, 0 1C to rt, 1 h, ii. CCl3CN, DBU, CH2Cl2, 0 1C, 15 min (a/b
mixture donor, for b and c) or CCl3CN, K2CO3, CH2Cl2, rt, 5 h (b donor, for d);
(b)TMSOTf, Et2O/CH2Cl2(6 : 1), 0 1C, 1 h, 87%; (c) TMSOTf, Et2O/CH2Cl2(6 : 1), rt,
1 h, 85%; (d) TMSOTf, CH2Cl2, rt, 30 min, 91%; (e) i. NaOMe, MeOH, rt, 1 h, ii.
Anisaldehyde dimethylacetal, CSA, DMF, rt, overnight, 86% (2 steps); (f) NapBr,
NaH, TBAI, DMF, rt, overnight, 88%; (g) NaCNBH3, TFA, THF/CH2Cl2, rt, 9 h, 80%;
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Acylation of alcohol 19 with linoleic acid using DCC/DMAP
and deprotection of the silyl group provided the desired alkylacyl-
glycerol 20 (Scheme 3). To obtain the required phosphoamidite
building block, glycerol derivative 20 was transformed into 4 using
the commercially available bis(diisopropylamino)(2-cyanoethoxy)-
phosphine and 1H-tetrazole.22
Ethyl-(2-azidoethyl)phosphonochloridate (5) and bis(chloro)-
(2-azidoethyl)phosphonate (5a) were obtained from commercially
available diethyl (2-bromoethyl)phosphonate. Starting with the
conversion of bromide into the corresponding azide 21,12 the
obtained ethyl phosphonate 21 was converted into chloro-
phosphonate 5 using a two-step protocol. First, ethylphosphonate
21 was hydrolyzed with LiBr to provide phosphonic acid mono
ethyl ester 22,23 which was converted into 5 by treatment with
oxalylchloride.24 Phosphonodichloridate 5a was synthesized
from ethyl phosphonate 21 via silylated intermediate 23, which
underwent reaction with oxalyl chloride.25
Two phosphorylation sequences of 3 were evaluated. In
the first case, the PMB group of pseudo-disaccharide 3 was
selectively removed under acidic conditions and without affecting
the Nap groups to obtain alcohol 24.16 This compound was further
phosphitylated with 5 in the presence of 1H-tetrazole and DIPEA.
Following reduction of the azides using DTT/DIPEA and amine
protection with Boc anhydride the phosphonate compound 26was
delivered, which was deallylated using PdCl2 and NaOAc in
AcOH. To complete the synthesis of the fully modified pseudo-
disaccharide, the free hydroxyl group of 27 was phosphitylated
with 4 and oxidized to the corresponding phosphorylated product
28 by using tert-butylhydroperoxide (Scheme 4).
Removal of the protecting groups from 2-aminoethylphos-
phonate proved to be more challenging than expected. High
stability of the phosphorous ethyl ester in 28 was observed after
reduction of the azide and Boc protection of the formed
amines. A variety of conditions were evaluated for the removal
of the ester (see ESI†); however they resulted in non-reaction or
in the decomposition of the starting material when long reaction
times and strong reaction conditions were used. As such, an
alternative assembly/deprotection sequence was needed. First,
the allyl group of pseudo-disaccharide 3 was removed in a
two-step protocol involving an iridium catalyzed isomerization
and hydrolysis with mercury chloride. The resulting free
hydroxyl group was phosphitylated with phosphoamidite 4
and oxidized with t-BuOOH to deliver phospholipidated
pseudo-dissacharide 30.
To install the 2-azidoethylphosphonate unit, the PMB on the
glucosamine of 30was selectively removed under acidic conditions
using 15% TFA in DCM (Scheme 5). Then the hydroxyl group was
reacted with 5a using 1H-tetrazole and DIPEA activation at 0 1C,
followed by the hydrolysis of the remaining chloride by addition of
water. The remaining protecting groups on the fully decorated
pseudo-disaccharide were removed via a three-step protocol.
Efficient removal of the cyanoethoxy group of the phospholipid
with DBU was followed by azide reduction with zinc in AcOH.
Different conditions were evaluated for the final removal of the
Nap groups. Methods involving oxidative conditions (DDQ)
delivered amixture of compounds due to incomplete deprotection.
However, by using TFA/toluene 8 : 1 at 0 1C, target 2 was
obtained in high yield (72% for the three deprotection steps)
after purification using size exclusion chromatography.26
In summary, a new strategy to obtain glycosylphosphatidyl-
inositol anchors containing unsaturated lipid chains has been
disclosed. The strategy is based on the use of 2-napthyl-methyl
ethers for permanent protection and allyl and PMB ethers as
orthogonal groups for masking positions requiring late stage
modifications. The synthesis of the required building blocks
demonstrated that the size of the Nap group did not affect the
reactivity of donors and acceptors and can easily replace benzyl
ether in established protocols. We described the synthesis of the
complex Glc-Ino pseudo-disaccharide core of the T. cruzi parasite
GPI, which bears a lipid moiety, and is modified by a linoleic acid
ester and a 2-aminophosphoethylamine. We demonstrated the
high stability of the Nap group in glycosylation and phosphorylation
reactions and its removal under acidic conditions without affecting
the phosphorylations, the alkyl ether on alkylacylglycerol, or the fatty
Scheme 3 Synthesis of phosphorylation synthons. Reagents and conditions:
(a) 1-Bromooctadecane, NaH, Toluene, 97%; (b) i. HCl, MeOH, 15%, ii. TBSCl,
Imidazole, DMF, 75%; (c) i. linoleic acid, DCC, DMAP, CH2Cl2, r.t., ii. BF3–
Et2O, CH2Cl2, 0 1C, 60% (over two steps); (d) bis(diisopropylamino)(2-
cyanoethoxy)phosphine, 1H-tetrazole, CH2Cl2, 90%; (e) LiBr, 2-pentanone,
110 1C, 2 h, quant.; (f) Oxalylchloride, DMF cat., CH2Cl2, rt, 1 h; (g) TMSBr,
CH2Cl2, 0 1C to rt, overnight.
Scheme 4 Reagents and conditions: (a) 15% TFA, CH2Cl2, 0 1C, 15 min,
91%; (b) 5, DIPEA, 1H-tetrazole, toluene, 0 1C to rt, overnight, 72%; (c) i.
dithiothreitol, DIPEA, MeCN/H2O, rt, 2 h, ii. Boc2O, DIPEA, MeOH, rt, 2 h,
86% (2 steps); (d) PdCl2, NaOAc, AcOH, rt, 6 h, 71%; (e) i. 4, 1H-tetrazole,
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acid containing the double bond. This strategy will enable
the synthesis of diverse glycosylphosphatidylinositols and other
glycolipids requiring unsaturated lipids and give access to pure
GPIs for biological investigation.
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